Association of bullous pemphigoid and Grover disease induced by immune checkpoint therapy
Saved in:
Main Authors: | Elena Lucía Pinto-Pulido (Author), Isabel Polo-Rodríguez (Author), Marta González-Cañete (Author), Ileana Medina-Expósito (Author), María Dolores Vélez-Velázquez (Author), Susana Medina-Montalvo (Author) |
---|---|
Format: | Book |
Published: |
Sociedade Brasileira de Dermatologia,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neutrophil-rich Variant of Persistent Bullous Grover's Disease
by: Sayaka Togo, et al.
Published: (2019) -
Bullous Pemphigoid in Patients Receiving Immune-Checkpoint Inhibitors and Psoriatic Patients-Focus on Clinical and Histopathological Variation
by: Dennis Niebel, et al.
Published: (2022) -
Inhibition of Transforming Growth Factor Beta and Immune Checkpoints Induces a Distinctively Distributed, Severe Bullous Pemphigoid
by: Soo Hyun Choi, et al.
Published: (2021) -
Bullous pemphigoid
by: Denise Miyamoto, et al. -
Bullous Grover’s Disease in a Chinese Tibetan Adolescent: A Case Report
by: Wang Q, et al.
Published: (2022)